Frequently Asked Questions for modified Rodnan Skin Score (mRSS) Certification
In scleroderma trials that have mRSS as an outcome measure of skin involvement it is essential to have consistent and accurate skin scoring. Some pharmaceutical companies may make mRSS certification mandatory for their trials and therefore certification is highly recommended.
Generally, pharmaceutical company trial sponsors require evidence of a minimum standard of competency and standardization to harmonize mRSS to conduct quality research. Certification provides this. Not all observational cohorts require mRSS certification.
If you receive certification in the context of a pharmaceutical sponsored clinical trial, please reach out directly to the pharmaceutical company. SCTC-WSF provide the mRSS certificates directly to the sponsor.
Re-certification is generally recommended by the SCTC and WSF every 3 years, especially if the individual is not conducting MRSS on scleroderma patients regularly.
To enquire about organizing a training course in the context of a clinical trial, please email us at mrss@sclerodermaclinicaltrialsconsortium.org or submit your details on our enquiry form here.
While in clinical practice ensuring you are doing the mRSS in the same way every time is important, for clinical trials certification an averaging technique is generally used.
The SCTC Database Committee maintains the list of MRSS certifications. To enquire about the mRSS certification list, please email us at mrss@sclerodermaclinicaltrialsconsortium.org or submit your details on our enquiry form here.
Become a Member of SCTC
Get involved
You can contribute to scleroderma research in several ways:
Join SCTC
Become a member and collaborate with experts in the field.
Support Our Mission
Your donations help fund critical research and clinical advancements.
Contact Us
For more information about SCTC, membership opportunities or ongoing research, reach out to us directly.